RECRUITING

Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Clinical Trial to Evaluate the Safety and Efficacy of Corneal Cross-linking in Subjects with Keratoconus.

Official Title

A Dose Ranging, Multicenter, Sham-Controlled Study to Evaluate the Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus

Quick Facts

Study Start:2022-03-08
Study Completion:2026-02
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05314738

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 55 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Provide written informed consent
  2. * Ability to hold gaze sufficiently stable for study testing
  3. * Willingness and ability to follow all instructions and comply with schedule for follow-up visits
  4. * Have a diagnosis of keratoconus
  1. * Known allergy or sensitivity to the test articles or components
  2. * Any disease causing abnormal topography other than keratoconus
  3. * Prior or current ocular condition (other than keratoconus) in the study eye that may predispose the eye for future complications

Contacts and Locations

Study Contact

Marco Armijo
CONTACT
562-761-7965
marmijo@glaukos.com

Study Locations (Sites)

Glaukos Investigative Site
Dothan, Alabama, 36301
United States
Glaukos Investigative Site
Teaneck, New Jersey, 07666
United States
Glaukos Investigative Site
Westerville, Ohio, 43082
United States

Collaborators and Investigators

Sponsor: Glaukos Corporation

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-03-08
Study Completion Date2026-02

Study Record Updates

Study Start Date2022-03-08
Study Completion Date2026-02

Terms related to this study

Keywords Provided by Researchers

  • Eye rubbing
  • Collagen cross-linking
  • Keratoconus
  • Progressive Keratoconus

Additional Relevant MeSH Terms

  • Progressive Keratoconus